ACRV insider buying and SEC filings, explained
Acrivon Therapeutics, Inc. · CIK 1781174
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$115K
Insiders who bought
3
Sold (not marked 10b5-1)
$41K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 22, 2026 | Sale | Mary Miller (Chief Legal Officer) sold 513 shares at about $1.84 ($944). Holdings down 1% to 81,202 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 26, 2026, 4:03 PM ET |
| Oct 5, 2026 | Sale | Mary Miller (Chief Legal Officer) sold 294 shares at about $1.99 ($585). Holdings down <1% to 81,715 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 5:02 PM ET |
| Aug 25, 2026 | Sale | Peter Blume-Jensen (CEO and Director) sold 14,036 shares at about $2.21 ($31K). Holdings down 1% to 2,230,052 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Aug 27, 2026 |
| Aug 18, 2026 | Sale | Katharine Peterson (Chief Accounting Officer) sold 101 shares at $2.01 ($203). Holdings down 1% to 18,033 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Sale | Mary Miller (Chief Legal Officer) sold 185 shares at $2.01 ($372). Holdings down <1% to 82,009 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Sale | Erick Gamelin (Chief Development Officer) sold 400 shares at $2.01 ($804). Holdings down 1% to 52,592 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Sale | Eric Devroe (President / COO) sold 604 shares at $2.01 ($1K). Holdings down <1% to 146,349 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Sale | Peter Blume-Jensen (CEO and Director) sold 1,713 shares directly and indirectly at $2.01 ($3K). Direct holdings down <1% to 2,244,088 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Aug 20, 2026 |
| Aug 4, 2026 | Sale | Adam D. Levy (CFO) sold 1,142 shares at $1.57 ($2K). Holdings down 2% to 66,008 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 6, 2026 |
| Jul 21, 2026 | Sale | Mary Miller (Chief Legal Officer) sold 573 shares at $1.76 ($1K). Holdings down 1% to 82,194 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 23, 2026 |
| Jan 14, 2026 | Purchase (code P) | Peter Blume-Jensen (CEO and Director) bought 49,000 shares at about $1.68 ($82K), reported as a purchase (code P). Holdings up 2% to 2,095,771 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 16, 2026 |
| Jan 14, 2026 | Purchase (code P) | Adam D. Levy (CFO) bought 8,832 shares at about $1.70 ($15K), reported as a purchase (code P). Holdings up 73% to 20,983 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 16, 2026 |
| Jan 13, 2026 | Purchase (code P) | Eric Devroe (President / COO) bought 10,000 shares at about $1.72 ($17K), reported as a purchase (code P). Holdings up 15% to 75,308 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 15, 2026 |
50 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
3 insiders bought in 30 days
$115K in purchases since Jan 13, 2026 · Purchases traded Jan 13, 2026 to Jan 14, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Eric Devroe (President / COO) | $17K | Jan 13, 2026 | SEC filing |
| Adam D. Levy (CFO) | $15K | Jan 14, 2026 | SEC filing |
| Peter Blume-Jensen (CEO) | $82K | Jan 14, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ACRV in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.